Get started
Author

Noa Efrat

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
2017 · Miguel Martin, Frankie A Holmes, et al. · The Lancet Oncology · 587
Economic Implications of 21-Gene Breast Cancer Risk Assay from the Perspective of an Israeli-Managed Health-Care Organization
2010 · Shmuel H. Klang, Ariel Hammerman, et al. · Value in Health · 113
Low-level constitutional mosaicism of a de novoBRCA1 gene mutation
2015 · E Friedman, N Efrat, et al. · British Journal of Cancer · 28
PDF
A phase II trial of trabectedin in triple-negative and HER2-overexpressing metastatic breast cancer
2016 · Joanne L. Blum, Anthony Gonçalves, et al. · Breast Cancer Research and Treatment · 19
Screening for germline mutations in breast/ovarian cancer susceptibility genes in high-risk families in Israel
2015 · Tamar Yablonski-Peretz, Shani Paluch-Shimon, et al. · Breast Cancer Research and Treatment · 19
Everolimus Plus Letrozole for Treatment of Patients With HR+, HER2– Advanced Breast Cancer Progressing on Endocrine Therapy: An Open-label, Phase II Trial
2017 · Tamar Safra, Bella Kaufman, et al. · Clinical Breast Cancer · 13
Preliminary safety and activity results of trabectedin in a phase II trial dedicated to triple-negative (ER-, PR-, HER2-), HER2+++, or BRCA1/2 germ-line-mutated metastatic breast cancer (MBC) patients (pts)
2009 · S. Delaloge, K. L. Tedesco, et al. · Journal of Clinical Oncology · 11
Abstract P2-13-21: Improved central nervous system outcomes in patients with early-stage HER2-positive breast cancer who receive neratinib for the recommended duration: Findings from the phase 3 ExteNET trial
2022 · Frankie Ann Holmes, Debra Patt, et al. · Cancer Research · 1
Abstract P4-12-09: Low-level constitutional mosaicism of a de novo BRCA1 gene mutation
2015 · Eitan Friedman, Noa Efrat, et al. · Cancer Research
433 Recurrence Score (RS) and Treatment Decisions in Node-positive (N+), Estrogen Receptor-positive (ER+) Breast Cancer Patients in Israel
2012 · S.M. Stemmer, N. Lieberman, et al. · European Journal of Cancer
Pcn55 the Impact of 21-gene Rt-pcrassay on Real Life Treatment Decisions in N−, Er+ Early-stage Breast Cancer Patients: It's Implication for Budget Impact Analysis
2007 · A Hammerman, SH Klang, et al. · Value in Health
PDF
Works count: 11
Citation count: 791
H-index: 7
I10-index: 7
Year
Topic
Type